Skip to main content

Advertisement

Log in

Bone Density in Ehlers-Danlos Syndrome

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract:

Ehlers-Danlos Syndrome (EDS) is the most common inherited disorder of connective tissue recognized. The objectives of the present study were to determine bone mineral density (BMD) and biochemical markers of bone metabolism in EDS. Twenty-three subjects with Type III EDS and 23 matched controls underwent BMD measurement by dual-Energy X-ray absorptiometry (DXA) of the lumbar spine and femoral neck. Health history questionnaires and biochemical markers of bone and connective tissue metabolism were also assessed. No significant differences in BMD at the lumbar spine or differences in biochemical markers of bone and connective tissue metabolism were found between EDS subjects and controls. EDS subjects had a significantly decreased BMD at the femoral neck compared with controls, but this difference disappeared after adjustment for body height, weight and physical activity levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 3 March 1999 / Accepted: 6 August 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carbone, L., Tylavsky, F., Bush, A. et al. Bone Density in Ehlers-Danlos Syndrome . Osteoporos Int 11, 388–392 (2000). https://doi.org/10.1007/s001980070104

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001980070104

Navigation